BioMarin Pharmaceutical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1996
Net Income	167.65	141.56	-64.08	854.03	-23.85	-77.21	-117.04	-630.21	-171.8	-133.97	Upgrade
Depreciation & Amortization	104.39	101.97	108.04	105.17	105.3	95.67	87.86	96.91	47.19	45.87	Upgrade
Share-Based Compensation	207.1	196.31	197.26	189.71	159.87	148.82	140.26	134.64	111.53	86.41	Upgrade
Other Operating Activities	-319.87	-263.94	63.31	-1,063.55	-193.06	-147.07	-119.84	170.82	-206.41	-68.73	Upgrade
Operating Cash Flow	159.26	175.9	304.54	85.37	48.26	20.21	-8.76	-227.84	-219.5	-70.42	Upgrade
Operating Cash Flow Growth	-9.46%	-42.24%	256.75%	76.88%	138.83%	-	-	-	-	-	Upgrade
Capital Expenditures	-96.69	-17.63	-95.58	-47.15	-120.03	-94.62	-199.22	-148.38	-227.65	-117.06	Upgrade
Acquisitions	0	0	0	0	0	0	0	-2.79	-910.15	0	Upgrade
Change in Investments	-3.63	8.19	-246.09	17.46	108.19	358.98	-229.49	-332.18	-448.47	248.99	Upgrade
Other Investing Activities	-10.92	-10.58	-24.64	-23.93	-19.19	-0.01	123.25	-0.7	406.67	64.4	Upgrade
Investing Cash Flow	-111.24	-20.03	-366.31	-53.62	-31.03	264.35	-305.46	-484.05	-1,179.6	196.33	Upgrade
Share Issuance / Repurchase	69.35	69.33	49.19	21.91	31.61	67.49	60.86	787.17	951.3	197.37	Upgrade
Debt Issued / Paid	-2.29	-2.61	-3.04	203.84	-5.09	-374.95	481.69	0	0	0	Upgrade
Other Financing Activities	-85.79	-85.38	-46.2	-44.64	-101.2	-80.54	-35.4	-60.06	-25.58	-13.17	Upgrade
Financing Cash Flow	-18.73	-18.65	-0.05	181.12	-74.67	-388.01	507.15	727.11	925.72	184.2	Upgrade
Exchange Rate Effect	1.31	0.03	-0.06	-1.15	0.9	-0.6	-3.23	-3.93	-5.07	-3.4	Upgrade
Net Cash Flow	30.6	137.26	-61.88	211.71	-56.54	-104.05	189.7	11.29	-478.45	306.71	Upgrade
Free Cash Flow	62.57	158.27	208.96	38.21	-71.76	-74.41	-207.98	-376.22	-447.15	-187.48	Upgrade
Free Cash Flow Growth	-60.47%	-24.26%	446.84%	-	-	-	-	-	-	-	Upgrade
Free Cash Flow Margin	2.59%	7.55%	11.32%	2.05%	-4.21%	-4.99%	-15.83%	-33.69%	-50.25%	-25.02%	Upgrade
Free Cash Flow Per Share	0.33	0.85	1.14	0.21	-0.40	-0.42	-1.19	-2.27	-2.79	-1.28	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).